arrow
O

Olivier Bousiges

Strasbourg University Hospital
H指数:24
被引数:2,150

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Alzheimer’s disease genetics converges on microglial and neuronal dysregulation

阿尔茨海默病遗传学研究聚焦于小胶质细胞和神经元功能失调

Nature
IF48.5
2026-10-280
OAAI
Salience and frontoparietal network impairments across disease stages in dementia with Lewy bodies: A comparative functional MRI study with Alzheimer's disease

路易体痴呆不同疾病阶段中的显著性及额顶网络损伤:一项与阿尔茨海默病的比较功能MRI研究

2025-10-170
PRE
Cognitive and neuroimaging outcome of very prodromal dementia with Lewy bodies

认知和神经影像学结局:路易体痴呆极早期前驱期

2025-05-250
PRE
Soluble SorLA in CSF, a novel biomarker to explore disrupted trafficking of SorLA protein in Alzheimer disease

脑脊液中的可溶性SorLA,一种探索阿尔茨海默病中SorLA蛋白转运障碍的新型生物标志物

2025-05-070
OA
Plasma biomarkers of amyloid, tau, axonal, and neuroinflammation pathologies in dementia with Lewy bodies

路易体痴呆中淀粉样蛋白,tau,轴突和神经炎症病理的血浆生物标志物

2024-07-032
OAAI
Association of Plasma Amyloid, P-Tau, GFAP, and NfL With CSF, Clinical, and Cognitive Features in Patients With Dementia With Lewy Bodies

路易体痴呆患者血浆淀粉样蛋白,p-tau,GFAP和NfL与CSF,临床和认知特征的关系

2024-06-253
OAAI
Prodromal characteristics of dementia with Lewy bodies: baseline results of the MEMENTO memory clinics nationwide cohort
2022-07-1922
OAAI
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview
2021-12-2231
OAAI
Association of cerebral microbleeds with cerebrospinal fluid Alzheimer-biomarkers and clinical symptoms in early dementia with Lewy bodies

脑微出血与脑脊液阿尔茨海默病的相关性-早期路易体痴呆的生物标志物和临床症状

2020-12-268
OAAI